Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Mesenchymal Stem Cells for Diabetic Foot
NCT02834858Phase 1Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of human umbilical cord mesenchymal stem cells in diabetic foot ulcer (DFU) and Peripheral Arterial Disease (PAD) (2 arms). Primary endpoint: Area of diabetic foot ulcers at 3 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
diabetic foot ulcer (DFU)Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02834858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02834858.